conjunctivitis%20-%20allergic,%20seasonal%20-and-%20perennial
CONJUNCTIVITIS - ALLERGIC, SEASONAL & PERENNIAL

Conjunctivitis is the inflammation of the conjunctiva.

Allergic conjunctivitis happens when the direct exposure of the ocular mucosal surfaces to the environment causes an immediate hypersensitivity reaction in which triggering antigens couple to reaginic antibodies (IgE) on the cell surface of mast cells and basophils, leading to the release of histamines that causes capillary dilation and increased permeability and thus conjunctival injection and swelling.
Seasonal allergic conjunctivitis is the most common form of allergic conjunctivitis in temperate climates. It usually occurs and recurs at a certain period of the year (eg summer).
Perennial allergic conjunctivitis manifests and recurs throughout the year with no seasonal predilection. It is most common in tropical climates.

Conjunctivitis%20-%20allergic,%20seasonal%20-and-%20perennial Management

Follow Up

  • Frequency depends on the severity of the disease, etiology, & treatment
  • Visual acuity should be measured & slit-lamp biomicroscopy should be performed
    • Intraocular pressure measurement & pupillary dilation should be done if corticosteroids have been used in treating patient’s chronic or recurrent conjunctivitis
      • Assesses possible side effect such as cataract & glaucoma
    • Baseline & periodic measurement is advised
  • Patients requiring repeat short-term topical corticosteroid therapy should be informed of its possible complications
  • Refer to a speciliast if w/ 
    • Eye that cannot open or be kept open
    • Marked pain or photophobia
    • History of trauma or foreign body
    • Copious or progressive discharge
    • Asymmetric or nonreactive pupil
    • Ciliary flush
    • Corneal opacity
    • Visual acuity loss
Editor's Recommendations
Most Read Articles
4 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 4 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
5 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.